Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular environment.

Talin is a protein that plays an important role in the immune system by activating integrins, receptors that help cells ...

Runaway cell death and inflammation triggered by severe trauma may be interrupted by a drug used to prevent alcohol abuse—and ...

Scientists have uncovered a mathematical pattern in species distribution, offering new insights into biodiversity and ecosystem restoration.

Antibody-drug conjugates dominated licensing activity in 2024. China’s biopharmaceutical sector saw a sharp rise in oncology ...

Quantum computing is not just another technological advancement—it’s a complete shift in the way we think about solving ...

ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focuson advanced or metastatic ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...

Bone-destructive diseases such as osteoporosis and chronic inflammatory arthritis affect millions of people worldwide, ...

A new study suggests blood and urine samples could provide an objective measure of diets and help unravel their connections ...